Previous Close | 6.30 |
Open | 6.27 |
Bid | 0.00 x 1400 |
Ask | 0.00 x 800 |
Day's Range | 5.93 - 6.50 |
52 Week Range | 3.98 - 8.24 |
Volume | |
Avg. Volume | 85,404 |
Market Cap | 185.525M |
Beta (5Y Monthly) | 3.15 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.05 |
Earnings Date | Aug 09, 2022 - Aug 15, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 14.40 |
Subscribe to Yahoo Finance Plus to view Fair Value for MIST
Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Joseph Oliveto, President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference on Thursday, June 9, 2022 at 1:30pm ET in New York, NY.
Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that Milestone's Compensation Committee granted three new employees incentive stock options to purchase an aggregate of 92,000 common shares, at a per share exercise price of $5.48, the closing price of Milestone's common stock on May 16, 2022. The awards were made pursuant to the NASDAQ inducement grant exception as a
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...